Figure 4From: What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDsRisk of myopathy, rhabdomyolysis and death from rhabdomyolysis with statins [65].Back to article page